Literature DB >> 2744730

HBcAg expressed on the surface of circulating Dane particles in patients with hepatitis B virus infection without evidence of anti-HBc formation.

B Möller1, U Hopf, R Stemerowicz, G Henze, H Gelderblom.   

Abstract

Circulating immune complexes composed of HBcAg and anti-HBc have been demonstrated recently in patients with hepatitis B virus replication. After dissociation of immune complexes by chaotropic ions, HBcAg was quantified radioimmunologically. In the present study, we describe 10 patients with hepatitis B virus replication, absent or delayed anti-HBc formation and exposed HBcAg in serum. Four of the 10 patients had acute hepatitis, and six patients had chronic persistent hepatitis. In seven of 10 patients, a secondary immune defect was apparent due to acquired immunodeficiency syndrome, leukemia, histiocytosis X, sarcoidosis or end-stage renal disease. Electron microscopy demonstrated that Dane particles from anti-HBc-negative patients were agglutinated after addition of monoclonal anti-HBc antibodies, whereas Dane particles from anti-HBc-positive sera did not show agglutination. Monoclonal HBsAg-specific antibodies aggregated Dane particles independent of the presence of anti-HBc. Circulating HBcAg was always associated with the Dane particle fraction after density gradient separation. Hepatitis B virus core proteins from patients with and without anti-HBc studied by immunoblotting after sodium dodecyl sulfate-gel electrophoresis showed identical patterns. Hepatocytes from anti-HBc-negative patients were positive for HBcAg but negative for immunoglobulin G by immunofluorescence technique. The data indicate that HBcAg may also be expressed on the surface of Dane particles, where it is commonly masked by anti-HBc.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2744730     DOI: 10.1002/hep.1840100210

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  7 in total

Review 1.  The underlying mechanisms for the "isolated positivity for the hepatitis B surface antigen (HBsAg)" serological profile.

Authors:  Robério Amorim de Almeida Pondé
Journal:  Med Microbiol Immunol       Date:  2010-05-11       Impact factor: 3.402

2.  Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection.

Authors:  V Avettand-Fenoel; D Thabut; C Katlama; T Poynard; V Thibault
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  Stability of the recombinant hepatitis B core antigen.

Authors:  N Nath; K Hickman; S Nowlan; D Shah; J Phillips; S Babler
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

4.  De novo hepatitis B surface antigen (HBsAg)-positive, core antibody (anti-HBc)-negative, hepatitis B virus infection post-liver transplant from an anti-HBc, HBsAg-negative donor.

Authors:  Harjot K Bedi; Roberto Trasolini; Christopher F Lowe; Trana Hussaini; Mark Bigham; Gordon Ritchie; Eric M Yoshida
Journal:  Hepatol Forum       Date:  2021-09-15

5.  Clinical significance of low or negative titer of antibody to hepatitis B core antigen during the course of chronic hepatitis B virus infection in adolescents.

Authors:  K Matsuura; K Tobe; Y Iwasaki; H Ikeda; K Takahashi; T Tsuji
Journal:  Gastroenterol Jpn       Date:  1993-02

Review 6.  Atypical serological profiles in hepatitis B virus infection.

Authors:  Robério A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-29       Impact factor: 3.267

7.  Acute hepatitis B virus infection with delayed appearance of hepatitis B core antibody in an immunocompromised patient: a case report.

Authors:  Nicholas Brousseau; Donald G Murphy; Vladimir Gilca; Jacynthe Larouche; Sema Mandal; Richard S Tedder
Journal:  J Med Case Rep       Date:  2017-04-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.